中证网讯 西藏药业（600211）3月7日晚间发布的重大资产购买预案显示，公司拟通过现金方式向跨国制药企业ASTRAZENECA的全资附属公司ASTRAZENECA AB购买其IMDUR产品、品牌和...
Zhongzheng Wang News Tibetan medicine (600,211) released late March 7 major asset purchase plan, the company intends to cash by multinational pharmaceutical companies ASTRAZENECA a wholly-owned subsidiary of the Company ASTRAZENECA AB IMDUR buy their products, brands and ...
